 |
MorphoSys AG
MOR
|
1.02 |
- |
2.43 % |
$ 254 M |
Germany |
 |
ARCA biopharma
ABIO
|
28.7 |
- |
1052.0 % |
$ 415 M |
USA |
 |
AbbVie
ABBV
|
3.18 |
$ 212.08 |
0.45 % |
$ 375 B |
USA |
 |
AbCellera Biologics
ABCL
|
3.48 |
$ 3.29 |
-1.94 % |
$ 983 M |
Canada |
 |
Aeterna Zentaris
AEZS
|
1.6 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.995 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 |
- |
- |
$ 1.01 B |
USA |
 |
AIkido Pharma
AIKI
|
6.48 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Akouos
AKUS
|
6.18 |
- |
0.23 % |
$ 488 M |
USA |
 |
Akero Therapeutics
AKRO
|
10.9 |
- |
- |
$ 3.67 B |
USA |
 |
I-Mab
IMAB
|
8.96 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
0.922 |
- |
2.54 % |
$ 160 B |
France |
 |
Albireo Pharma
ALBO
|
2.39 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Biophytis SA
BPTS
|
1.34 |
- |
-13.47 % |
$ 169 M |
France |
 |
Aileron Therapeutics
ALRN
|
3.34 |
- |
10.36 % |
$ 9.8 M |
USA |
 |
Aptinyx
APTX
|
2.35 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Midatech Pharma plc
MTP
|
2.29 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
10.8 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 |
- |
- |
$ 26.5 M |
USA |
 |
Avenue Therapeutics
ATXI
|
3.27 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 |
- |
- |
$ 7.46 M |
Israel |
 |
Atreca
BCEL
|
2.02 |
- |
-11.76 % |
$ 5.79 M |
USA |
 |
Acorda Therapeutics
ACOR
|
1.61 |
- |
-24.86 % |
$ 820 K |
USA |
 |
bluebird bio
BLUE
|
1.46 |
- |
- |
$ 546 M |
USA |
 |
Acasti Pharma
ACST
|
13.4 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 |
- |
- |
- |
Russia |
 |
Avid Bioservices
CDMO
|
1.22 |
- |
- |
$ 789 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
1.65 |
- |
- |
$ 86.2 M |
USA |
 |
Acer Therapeutics
ACER
|
0.41 |
- |
2.71 % |
$ 14 M |
USA |
 |
Advaxis
ADXS
|
5.93 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
1.78 |
$ 12.29 |
-11.96 % |
$ 1.86 B |
USA |
 |
BeiGene, Ltd.
BGNE
|
2.14 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
BioDelivery Sciences International
BDSI
|
2.37 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Cara Therapeutics
CARA
|
1.83 |
- |
-3.03 % |
$ 260 M |
USA |
 |
ChemoCentryx
CCXI
|
3.05 |
- |
- |
$ 3.74 B |
USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
6.76 |
$ 1.08 |
-1.38 % |
$ 22.2 M |
Israel |
 |
Enochian Biosciences
ENOB
|
0.278 |
- |
- |
$ 40.5 M |
USA |
 |
CureVac N.V.
CVAC
|
2.47 |
- |
- |
$ 867 M |
Germany |
 |
Summit Therapeutics
SMMT
|
8.14 |
$ 16.55 |
-4.11 % |
$ 12.4 B |
Britain |
 |
Bellerophon Therapeutics
BLPH
|
1.47 |
- |
-74.18 % |
$ 955 K |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
1.19 |
$ 319.85 |
-2.53 % |
$ 41.9 B |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
5.24 |
$ 4.34 |
-2.47 % |
$ 832 M |
Canada |
 |
Allakos
ALLK
|
3.26 |
- |
- |
$ 28.6 M |
USA |
 |
Brickell Biotech
BBI
|
5.28 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
2.53 |
- |
- |
$ 384 M |
Britain |
 |
Allena Pharmaceuticals
ALNA
|
2.19 |
- |
3.16 % |
$ 1.9 M |
USA |
 |
Calithera Biosciences
CALA
|
4.13 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Fusion Pharmaceuticals
FUSN
|
4.51 |
- |
- |
$ 1.41 B |
Canada |